Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70867 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2026. Written by Iad Alhallak and 8 co-authors. Institution: Department of Cardiovascular Disease, McGovern Medical School at UTHealth Houston, Houston, Texas, USA. Major MEDLINE topics: Aortic Valve Stenosis, Stents, Transcatheter Aortic Valve Replacement, Blood Vessel Prosthesis. 19 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Objectives
To evaluate the feasibility and short‐term outcomes of transcatheter aortic valve replacement (TAVR) using balloon‐expandable Sapien valves in patients with prior endovascular aortic stent grafts.
Methods
We conducted a single‐center, retrospective study of 23 patients with prior endovascular aortic stent grafts who underwent TAVR between 2012 and 2025 using Sapien platform balloon‐expandable valves. Descriptive statistics and univariate logistic regression analysis were used to characterize and identify outcomes of peri‐procedural complications.
Results
Transfemoral access was used in 87% of cases, and valve deployment was successful in all patients without aortic injuries or graft‐related complications during the procedural and up to 30‐day post‐procedure period. Median length of stay was 3 days, and there were no deaths up to 30‐days. Post‐procedural events were infrequent and included new‐onset atrial fibrillation ( n = 2), transient hemodialysis ( n = 1), pleural effusion ( n = 1), and stroke ( n = 1). In exploratory analyses limited by the small number of events, older age (OR 1.27, 95% CI 1.04–1.71) and higher baseline mean aortic‐valve gradient (OR 1.24, 95% CI 1.06–1.76) were associated with periprocedural events.
Conclusions
The complications observed in our cohort are general outcomes associated with TAVR, instead of graft‐associated outcomes. Balloon‐expandable TAVR is technically safe and feasible in patients with prior endovascular aortic stent grafts when performed at experienced centers.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiovascular Disease, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
- Department of Cardiothoracic and Vascular Surgery, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
ORCID profiles: Iad Alhallak, Ken Chan, Biswajit Kar, Richard Smalling
Cite
APA
Alhallak, I., Mills, A., Bequeaith, B., Chan, K., Tanaka, A., Estrera, A. L., Kar, B., Smalling, R., & Dhoble, A. (2026). Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70867
Vancouver
Alhallak I, Mills A, Bequeaith B, Chan K, Tanaka A, Estrera AL, et al. Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70867
BibTeX
@article{Alhallak2026,
author = {Alhallak, Iad and Mills, Alexander and Bequeaith, Beau and Chan, Ken and Tanaka, Akiko and Estrera, Anthony L and Kar, Biswajit and Smalling, Richard and Dhoble, Abhijeet},
title = {Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70867}
}
EUVIMED